{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:22:44Z","timestamp":1792812164101,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Engineering Microbiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.engmic.2025.100222","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:19:40Z","timestamp":1751429980000},"page":"100222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The role of microbiota dysbiosis in Parkinson\u2019s disease: Pathophysiology and therapeutic opportunities"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6747-5777","authenticated-orcid":false,"given":"Shabnam","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-0333","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Caicedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.engmic.2025.100222_bib0001","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet. Neurol"},{"key":"10.1016\/j.engmic.2025.100222_bib0002","unstructured":"World Health Organization. Parkinson disease [Internet]. Parkinson. Disease. (2023). [cited 2024 Sep 1]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease"},{"key":"10.1016\/j.engmic.2025.100222_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","article-title":"Current and projected future economic burden of Parkinson\u2019s disease in the U.S","volume":"6","author":"Yang","year":"2020","journal-title":"npj. Parkinsons. Disease"},{"issue":"6","key":"10.1016\/j.engmic.2025.100222_bib0004","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/14728222.2023.2277240","article-title":"Mitochondria makeover: unlocking the path to healthy longevity","volume":"28","author":"Caicedo","year":"2024","journal-title":"Expert. Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.engmic.2025.100222_bib0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.engmic.2025.100222_bib0006","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ejn.14119","article-title":"l-DOPA for Parkinson\u2019s disease-a bittersweet pill","volume":"49","author":"Lane","year":"2019","journal-title":"Eur. J. Neurosci"},{"issue":"8","key":"10.1016\/j.engmic.2025.100222_bib0007","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3233\/JPD-223461","article-title":"Exploring the connection between the gut microbiome and parkinson\u2019s disease symptom progression and pathology: implications for supplementary treatment options","volume":"12","author":"Chan","year":"2022","journal-title":"J. Parkinsons. Dis"},{"issue":"11","key":"10.1016\/j.engmic.2025.100222_bib0008","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J"},{"issue":"3","key":"10.1016\/j.engmic.2025.100222_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10030578","article-title":"Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options","volume":"10","author":"Hrncir","year":"2022","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.engmic.2025.100222_bib0010","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4103\/1673-5374.335837","article-title":"The influence of gut microbiota alteration on age-related neuroinflammation and cognitive decline","volume":"17","author":"Alsegiani","year":"2022","journal-title":"Neural. Regen. Res"},{"issue":"3","key":"10.1016\/j.engmic.2025.100222_bib0011","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mds.27924","article-title":"Antibiotic exposure and risk of Parkinson\u2019s disease in Finland: a nationwide case-control study","volume":"35","author":"Mertsalmi","year":"2020","journal-title":"Mov. Disord"},{"issue":"11","key":"10.1016\/j.engmic.2025.100222_bib0012","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet. Neurol"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40120-024-00687-6","article-title":"Sex differences in parkinson\u2019s disease: a narrative review","volume":"14","author":"Cattaneo","year":"2025","journal-title":"Neurol. Ther"},{"issue":"9996","key":"10.1016\/j.engmic.2025.100222_bib0014","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.engmic.2025.100222_bib0016","article-title":"Neuropathology of Parkinson disease","volume":"46","author":"Dickson","year":"2018","journal-title":"Parkinsonism. Relat. Disord"},{"key":"10.1016\/j.engmic.2025.100222_bib0017","first-page":"1516","article-title":"The rho termination factor of Clostridium botulinum contains a prion-like domain with a highly amyloidogenic core","volume":"6","author":"Pallar\u00e8s","year":"2015","journal-title":"Front. Microbiol"},{"issue":"6321","key":"10.1016\/j.engmic.2025.100222_bib0018","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.aai7776","article-title":"A bacterial global regulator forms a prion","volume":"355","author":"Yuan","year":"2017","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.engmic.2025.100222_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov. Disord"},{"issue":"8","key":"10.1016\/j.engmic.2025.100222_bib0020","article-title":"Gut Vibes in Parkinson\u2019s Disease: the microbiota-Gut-brain axis","volume":"6","author":"Bullich","year":"2019","journal-title":"Mov. Disord. Clin. Pract. (Hoboken)"},{"key":"10.1016\/j.engmic.2025.100222_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/bs.pmbts.2019.06.013","article-title":"Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer\u2019s disease","volume":"168","author":"Westfall","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci"},{"key":"10.1016\/j.engmic.2025.100222_bib0022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing. Res. Rev"},{"issue":"7541","key":"10.1016\/j.engmic.2025.100222_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/nature14232","article-title":"Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome","volume":"519","author":"Chassaing","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.engmic.2025.100222_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.11.007","article-title":"Dietary fiber and SCFAs in the regulation of mucosal immunity","volume":"151","author":"Tan","year":"2023","journal-title":"J. Allergy. Clin. Immunol"},{"issue":"3","key":"10.1016\/j.engmic.2025.100222_bib0025","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1002\/mco2.268","article-title":"Ketogenic diet protects MPTP-induced mouse model of Parkinson\u2019s disease via altering gut microbiota and metabolites","volume":"4","author":"Jiang","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0026","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: an emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal. Transduct. Target. Ther"},{"issue":"5","key":"10.1016\/j.engmic.2025.100222_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.engmic.2025.100222_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1217306","article-title":"Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota","volume":"14","author":"Tian","year":"2023","journal-title":"Front. Pharmacol"},{"key":"10.1016\/j.engmic.2025.100222_bib0029","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3389\/fphar.2020.01153","article-title":"NSAID-gut microbiota interactions","volume":"11","author":"Maseda","year":"2020","journal-title":"Front. Pharmacol"},{"issue":"7","key":"10.1016\/j.engmic.2025.100222_bib0030","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-2257","article-title":"Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial","volume":"44","author":"Mueller","year":"2021","journal-title":"Diabetes. Care"},{"issue":"8","key":"10.1016\/j.engmic.2025.100222_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14190","article-title":"Aging amplifies a gut microbiota immunogenic signature linked to heightened inflammation","volume":"23","author":"Caetano-Silva","year":"2024","journal-title":"Aging. Cell"},{"issue":"6","key":"10.1016\/j.engmic.2025.100222_bib0032","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mp.2016.46","article-title":"Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition","volume":"21","author":"Wong","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.engmic.2025.100222_bib0033","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3389\/fimmu.2020.01783","article-title":"Circadian host-microbiome interactions in immunity","volume":"11","author":"Butler","year":"2020","journal-title":"Front. Immunol"},{"key":"10.1016\/j.engmic.2025.100222_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.puhe.2024.10.035","article-title":"Environmental and occupational exposure to organochlorine pesticides associated with Parkinson\u2019s disease risk: a systematic review and meta-analysis based on epidemiological evidence","volume":"237","author":"Xu","year":"2024","journal-title":"Public. Health"},{"key":"10.1016\/j.engmic.2025.100222_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1348279","article-title":"Dysbiosis of the gut microbiota and its effect on \u03b1-synuclein and prion protein misfolding: consequences for neurodegeneration","volume":"14","author":"Mahbub","year":"2024","journal-title":"Front. Cell. Infect. Microbiol"},{"issue":"4","key":"10.1016\/j.engmic.2025.100222_bib0036","doi-asserted-by":"crossref","DOI":"10.1177\/08919887211018268","article-title":"The role of the gut microbiome in parkinson\u2019s disease","volume":"34","author":"Gallop","year":"2021","journal-title":"J. Geriatr. Psychiatry. Neurol"},{"issue":"9","key":"10.1016\/j.engmic.2025.100222_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28119","article-title":"Meta-analysis of gut dysbiosis in Parkinson\u2019s disease","volume":"35","author":"Nishiwaki","year":"2020","journal-title":"Mov. Disord"},{"issue":"8","key":"10.1016\/j.engmic.2025.100222_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081738","article-title":"The gut microbiome as a catalyst and emerging therapeutic target for parkinson\u2019s disease: a comprehensive update","volume":"12","author":"Kerstens","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.engmic.2025.100222_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112444","article-title":"Association between increased and decreased gut microbiota abundance and Parkinson\u2019s disease: a systematic review and subgroup meta-analysis","volume":"191","author":"Bai","year":"2024","journal-title":"Exp. Gerontol"},{"issue":"24","key":"10.1016\/j.engmic.2025.100222_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells11244038","article-title":"Role of endogenous lipopolysaccharides in neurological disorders","volume":"11","author":"Kalyan","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.engmic.2025.100222_bib0041","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2036.2007.03562.x","article-title":"Review article: the role of butyrate on colonic function","volume":"27","author":"Hamer","year":"2008","journal-title":"Aliment. Pharmacol. Ther"},{"issue":"9","key":"10.1016\/j.engmic.2025.100222_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/nu15092211","article-title":"Short-chain fatty-acid-producing bacteria: key components of the Human gut microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.engmic.2025.100222_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103092","article-title":"Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to Parkinson\u2019s disease and therapeutic implications","volume":"71","author":"Kalyanaraman","year":"2024","journal-title":"Redox. Biol"},{"key":"10.1016\/j.engmic.2025.100222_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.708587","article-title":"What is our understanding of the influence of gut microbiota on the pathophysiology of parkinson\u2019s disease?","volume":"15","author":"Hill","year":"2021","journal-title":"Front. Neurosci"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal. Transduct. Target. Ther"},{"key":"10.1016\/j.engmic.2025.100222_bib0046","article-title":"Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s","volume":"12","author":"Li","year":"2021","journal-title":"Disease.. Front. Immunol."},{"issue":"15","key":"10.1016\/j.engmic.2025.100222_bib0047","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025847118","article-title":"Soluble \u03b1-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia","volume":"118","author":"Trudler","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.engmic.2025.100222_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1506358","article-title":"Microglia: roles and genetic risk in Parkinson\u2019s disease","volume":"18","author":"Trainor","year":"2024","journal-title":"Front. Neurosci"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0049","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","article-title":"Diet and the gut microbiome in patients with Parkinson\u2019s disease","volume":"10","author":"Kwon","year":"2024","journal-title":"npj. Parkinsons. Disease"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-025-03454-y","article-title":"Elucidating the specific mechanisms of the gut-brain axis: the short-chain fatty acids-microglia pathway","volume":"22","author":"Cao","year":"2025","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0051","doi-asserted-by":"crossref","DOI":"10.1111\/cns.13990","article-title":"Gut bacterial profiles in Parkinson\u2019s disease: a systematic review","volume":"29","author":"Li","year":"2023","journal-title":"CNS. Neurosci. Ther"},{"key":"10.1016\/j.engmic.2025.100222_bib0052","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40035-019-0175-7","article-title":"Microbiome changes: an indicator of Parkinson\u2019s disease?","volume":"8","author":"Haikal","year":"2019","journal-title":"Transl. Neurodegener"},{"issue":"11","key":"10.1016\/j.engmic.2025.100222_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8110502","article-title":"Effects of antibiotics upon the gut microbiome: a review of the literature","volume":"8","author":"Konstantinidis","year":"2020","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.engmic.2025.100222_bib0054","article-title":"Association of gut microbiome dysbiosis with neurodegeneration: can gut microbe-modifying diet prevent or alleviate the symptoms of neurodegenerative diseases?","volume":"11","author":"Tan","year":"2021","journal-title":"Life. (Basel)"},{"issue":"3","key":"10.1016\/j.engmic.2025.100222_bib0055","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord"},{"key":"10.1016\/j.engmic.2025.100222_bib0056","first-page":"691","volume":"44","author":"Aho","year":"2019"},{"issue":"6","key":"10.1016\/j.engmic.2025.100222_bib0057","doi-asserted-by":"crossref","DOI":"10.1007\/s10517-017-3700-7","article-title":"Analysis of gut microbiota in patients with Parkinson\u2019s disease","volume":"162","author":"Petrov","year":"2017","journal-title":"Bull. Exp. Biol. Med"},{"issue":"10","key":"10.1016\/j.engmic.2025.100222_bib0058","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson\u2019s disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord"},{"key":"10.1016\/j.engmic.2025.100222_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2017.04.019","article-title":"Gut microbiota in Parkinson disease in a northern German cohort","volume":"1667","author":"Hopfner","year":"2017","journal-title":"Brain. Res"},{"key":"10.1016\/j.engmic.2025.100222_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2019.06.003","article-title":"Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients","volume":"65","author":"Pietrucci","year":"2019","journal-title":"Parkinsonism. Relat. Disord"},{"key":"10.1016\/j.engmic.2025.100222_bib0061","volume":"5","author":"Tan","year":"2021"},{"issue":"15","key":"10.1016\/j.engmic.2025.100222_bib0062","doi-asserted-by":"crossref","DOI":"10.1039\/D3FO00728F","article-title":"Effect of lacticaseibacillus paracasei strain Shirota supplementation on clinical responses and gut microbiome in Parkinson\u2019s disease","volume":"14","author":"Yang","year":"2023","journal-title":"Food. Funct"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0063","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.01191-21","article-title":"Parkinson\u2019s disease medication alters small intestinal motility and microbiota composition in healthy rats","volume":"7","author":"van Kessel","year":"2022","journal-title":"mSystems"},{"key":"10.1016\/j.engmic.2025.100222_bib0064","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnmol.2019.00171","article-title":"Gut microbiota differs between parkinson\u2019s disease patients and healthy controls in northeast china","volume":"12","author":"Li","year":"2019","journal-title":"Front. Mol. Neurosci"},{"key":"10.1016\/j.engmic.2025.100222_bib0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","article-title":"Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease","volume":"70","author":"Qian","year":"2018","journal-title":"Brain. Behav. Immun"},{"issue":"9","key":"10.1016\/j.engmic.2025.100222_bib0066","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.2305","article-title":"Fecal microbiota transplantation for treatment of parkinson disease: a randomized clinical trial","volume":"81","author":"Scheperjans","year":"2024","journal-title":"JAMA. Neurol"},{"key":"10.1016\/j.engmic.2025.100222_bib0067","article-title":"Efficacy and safety of probiotics in Parkinson\u2019s constipation: a systematic review and meta-analysis","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Pharmacol"},{"issue":"2","key":"10.1016\/j.engmic.2025.100222_bib0068","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2284247","article-title":"Efficacy of fecal microbiota transplantation in patients with Parkinson\u2019s disease: clinical trial results from a randomized, placebo-controlled design","volume":"15","author":"Cheng","year":"2023","journal-title":"Gut. Microbes"},{"key":"10.1016\/j.engmic.2025.100222_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102563","article-title":"Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"71","author":"Bruggeman","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.engmic.2025.100222_bib0070","series-title":"The Safety and Feasibility of Mediterranean-Ketogenic Dietary Interventions on Gut Health in Parkinson\u2019s Disease: A Protocol For an Open-label, Randomized, Crossover Design Clinical Trial","author":"Keymanesh","year":"2023"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-230366","article-title":"Dietary interventions in parkinson\u2019s disease","volume":"14","author":"van der Berg","year":"2024","journal-title":"J. Parkinsons. Dis"},{"issue":"5","key":"10.1016\/j.engmic.2025.100222_bib0072","doi-asserted-by":"crossref","DOI":"10.1038\/s41430-024-01411-1","article-title":"Effects of dietary supplements, foods, and dietary patterns in Parkinson\u2019s disease: meta-analysis and systematic review of randomized and crossover studies","volume":"78","author":"Wu","year":"2024","journal-title":"Eur. J. Clin. Nutr"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0073","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41531-022-00327-6","article-title":"Probiotics synergized with conventional regimen in managing Parkinson\u2019s disease","volume":"8","author":"Sun","year":"2022","journal-title":"npj. Parkinsons. Disease"},{"issue":"2","key":"10.1016\/j.engmic.2025.100222_bib0074","article-title":"Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients","volume":"57","author":"Cassani","year":"2011","journal-title":"Minerva. Gastroenterol. Dietol"},{"issue":"12","key":"10.1016\/j.engmic.2025.100222_bib0075","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003127","article-title":"Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT","volume":"87","author":"Barichella","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.engmic.2025.100222_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","article-title":"Gut microbiota: implications in Parkinson\u2019s disease","volume":"38","author":"Parashar","year":"2017","journal-title":"Parkinsonism. Relat. Disord"},{"issue":"5","key":"10.1016\/j.engmic.2025.100222_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u2019s disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int"},{"issue":"5","key":"10.1016\/j.engmic.2025.100222_bib0078","article-title":"Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson\u2019s disease models","volume":"12","author":"Castelli","year":"2020","journal-title":"Aging. (Albany. NY)"},{"issue":"2","key":"10.1016\/j.engmic.2025.100222_bib0079","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/15321819.2020.1833917","article-title":"Neuroprotective effects of probiotics bacteria on animal model of Parkinson\u2019s disease induced by 6-hydroxydopamine: a behavioral, biochemical, and histological study","volume":"42","author":"Alipour Nosrani","year":"2021","journal-title":"J. Immunoassay. Immunochem"},{"issue":"3","key":"10.1016\/j.engmic.2025.100222_bib0080","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji","year":"2019","journal-title":"Clin. Nutr"},{"key":"10.1016\/j.engmic.2025.100222_bib0081","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5633403","article-title":"Next-generation probiotics: microflora intervention to Human diseases","volume":"2022","author":"Zhang","year":"2022","journal-title":"Biomed. Res. Int"},{"issue":"1","key":"10.1016\/j.engmic.2025.100222_bib0082","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11033-024-09398-5","article-title":"Next-generation probiotics: the upcoming biotherapeutics","volume":"51","author":"Al-Fakhrany","year":"2024","journal-title":"Mol. Biol. Rep"},{"issue":"22","key":"10.1016\/j.engmic.2025.100222_bib0083","doi-asserted-by":"crossref","DOI":"10.3390\/nu14224886","article-title":"Neurotrophic role of the next-generation probiotic strain L. lactis MG1363-pMG36e-GLP-1 on Parkinson\u2019s disease via inhibiting ferroptosis","volume":"14","author":"Yue","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.engmic.2025.100222_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109564","article-title":"Dysbiosis in Parkinson\u2019s disease might be triggered by certain antibiotics","volume":"137","author":"Tern\u00e1k","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"7","key":"10.1016\/j.engmic.2025.100222_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson\u2019s disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet. Neurol"},{"issue":"2","key":"10.1016\/j.engmic.2025.100222_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet. Neurol"}],"container-title":["Engineering Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667370325000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667370325000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:32:07Z","timestamp":1758688327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667370325000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2667370325000360"],"URL":"https:\/\/doi.org\/10.1016\/j.engmic.2025.100222","relation":{},"ISSN":["2667-3703"],"issn-type":[{"value":"2667-3703","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of microbiota dysbiosis in Parkinson\u2019s disease: Pathophysiology and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Engineering Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.engmic.2025.100222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Shandong University.","name":"copyright","label":"Copyright"}],"article-number":"100222"}}